The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
Open accessAbstract
BACKGROUND Myocardial injury after non-cardiac surgery (MINS) increases the risk of cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran prevents perioperative venous thromboembolism, but whether this drug can prevent a broader range of vascular complications in patients with MINS is unknown. The MANAGE trial assessed the potential of dabigatran to prevent major vascular complications among such patients. METHODS In this international, randomised, placebo-controlled trial, we recruited patients from 84 hospitals in 19 countries. Eligible patients were aged at least 45 years, had undergone non-cardiac surgery, and were within 35 days of MINS. Patients were randomly assigned (1:1) to receive dabigatran 110 mg orally twice daily or matched placebo for a maximum of 2 years or until termination of the trial and, using a partial 2-by-2 factorial design, patients not taking a proton-pump inhibitor were also randomly assigned (1:1) to omeprazole 20 mg once daily, for which results will be reported elsewhere, or matched placebo to measure its effect on major upper gastrointestinal complications. Research personnel randomised patients through a central 24 h computerised randomisation system using block randomisation, stratified by centre. Patients, health-care providers, data collectors, and outcome adjudicators were masked to treatment allocation. The primary efficacy outcome was the occurrence of a major vascular complication, a composite of vascular mortality and non-fatal myocardial infarction, non-haemorrhagic stroke, peripheral arterial thrombosis, amputation, and symptomatic venous thromboembolism. The primary safety outcome was a composite of life-threatening, major, and critical organ bleeding. Analyses were done according to the intention-to-treat principle. This trial is registered with ClinicalTrials.gov, number NCT01661101. FINDINGS Between Jan 10, 2013, and July 17, 2017, we randomly assigned 1754 patients to receive dabigatran (n=877) or placebo (n=877); 556 patients were also randomised in the omeprazole partial factorial component. Study drug was permanently discontinued in 401 (46%) of 877 patients allocated to dabigatran and 380 (43%) of 877 patients allocated to placebo. The composite primary efficacy outcome occurred in fewer patients randomised to dabigatran than placebo (97 [11%] of 877 patients assigned to dabigatran vs 133 [15%] of 877 patients assigned to placebo; hazard ratio [HR] 0·72, 95% CI 0·55-0·93; p=0·0115). The primary safety composite outcome occurred in 29 patients (3%) randomised to dabigatran and 31 patients (4%) randomised to placebo (HR 0·92, 95% CI 0·55-1·53; p=0·76). INTERPRETATION Among patients who had MINS, dabigatran 110 mg twice daily lowered the risk of major vascular complications, with no significant increase in major bleeding. Patients with MINS have a poor prognosis; dabigatran 110 mg twice daily has the potential to help many of the 8 million adults globally who have MINS to reduce their risk of a major vascular complication [corrected]. FUNDING Boehringer Ingelheim and Canadian Institutes of Health Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Self-citationSCHULMAN, S., & KEARON, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01204.x · Cited by 5,009
Self-citationMehran, R., Rao, S. V., Bhatt, D. L., Gibson, C. M., Caixeta, A., Eikelboom, J., Kaul, S., Wiviott, S. D., Menon, V., Nikolsky, E., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.009449 · Cited by 4,476
Self-citationSCHULMAN, S., ANGERÅS, U., BERGQVIST, D., ERIKSSON, B., LASSEN, M. R., & FISHER, W. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03678.x · Cited by 3,756
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Third Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D. (2012) · Circulation · doi:10.1161/cir.0b013e31826e1058 · Cited by 2,985
Rivaroxaban with or without aspirin in stable cardiovascular disease
Eikelboom, J. W., Connolly, S. J., Bosch, J., Dagenais, G. R., Hart, R. G., Shestakovska, O., Diaz, R., Alings, M., Lonn, E. M., Anand, S. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709118 · Cited by 2,438
Self-citationPeduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Mega, J. L., Braunwald, E., Wiviott, S. D., Bassand, J.-P., Bhatt, D. L., Bode, C., Burton, P., Cohen, M., Cook-Bruns, N., Fox, K. A. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112277 · Cited by 1,897
Cited by
Halvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., De Hert, S., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,141
Self-citationThompson, A., Fleischmann, K. E., Smilowitz, N. R., de las Fuentes, L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001285 · Cited by 365
Sandoval, Y., & Jaffe, A. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.018 · Cited by 297
Ruetzler, K., Smilowitz, N. R., Berger, J. S., Devereaux, P. J., Maron, B. A., Newby, L. K., de Jesus Perez, V., Sessler, D. I., Wijeysundera, D. N., & on behalf of the American Heart Association Council on Cardiopulmonary, C. C. (2021) · Circulation · doi:10.1161/cir.0000000000001024 · Cited by 279
Self-citation
Metadata
- Authors
- Devereaux, P. J., Duceppe, E., Guyatt, G., Tandon, V., Rodseth, R., Biccard, B. M., Xavier, D., Szczeklik, W., Meyhoff, C. S., Vincent, J., Franzosi, M. G., Srinathan, S. K., Erb, J., Magloire, P., Neary, J., Rao, M., Rahate, P. V., Chaudhry, N. K., Mayosi, B., de Nadal, M., Iglesias, P. P., Berwanger, O., Villar, J. C., Botto, F., Eikelboom, J. W., Sessler, D. I., Kearon, C., Pettit, S., Sharma, M., Connolly, S. J., Bangdiwala, S. I., Rao-Melacini, P., Hoeft, A., Yusuf, S., Devereaux, P. J., Duceppe, E., Bangdiwala, S. I., Connolly, S., Eikelboom, J., Guyatt, G., Kearon, C., Pettit, S., Pogue, J., Rodseth, R., Sessler, D. I., Vincent, J., Yusuf, S., Vincent, J., Di Diodato, S., Gasic, Z., Mastrangelo, L. J., Molnar, S. H., Pettit, S., Swanson, J. L., Tosh, M. L., Wells, J. R., Botto, F., Diaz, R., Chow, C. K., Berwanger, O., Gonzales, B., Devereaux, P. J., Tandon, V., Villar, J. C., Vásquez, S., Jansky, P., Dušek, R., Meyhoff, C. S., Coriat, P., Hoeft, A., Wittmann, M., Yonga, G., Xavier, D., Rao, M., Mathur, N., Franzosi, M. G., Seletti, E., Malaga, G., Tumanan-Mendoza, B. A., Tagle, M. P. A., Szczeklik, W., Biccard, B. M., Alonso-Coello, P., Popova, E., Shields, M., Sessler, D. I., Devereaux, P. J., Biccard, B. M., Connolly, S., Duceppe, E., Eikelboom, J., Guyatt, G., Hoeft, A., Jansky, P., Kearon, C., Le Manach, Y., Moayyedi, P., Pettit, S., Pogue, J., Rodseth, R., Sessler, D. I., van Zanten, S., Villar, J. C., Vincent, J., Yusuf, S., Devereaux, P. J., Alonso-Coello, P., Berwanger, O., Biccard, B. M., Botto, F., Chow, C. K., Connolly, S., Coriat, P., Diaz, R., Duceppe, E., Eikelboom, J., Fleischmann, E., Franzosi, M. G., Garg, A., Guyatt, G., Hoeft, A., Jansky, P., Karaye, K., Kearon, C., Le Manach, Y., Malaga, G., McFalls, E., Meyhoff, C. S., Moayyedi, P., Pettit, S., Pogue, J., Rodseth, R., Sessler, D. I., Sigamani, A., Shields, M., Szczeklik, W., Tumanan-Mendoza, B. A., van Zanten, S., Villar, J. C., Vincent, J., Xavier, D., Yonga, G., Yusuf, S., Connolly, S., Belley-Côté, E., Biedroń, G., Borges, F., Frosi Stella, S., Haarmark Nielsen, C., Leong, D. P., Meyhoff, C. S., Spence, J., Tran, A., Wawrzycka-Adamczyk, K., Yang, S. S., Yung, T., Wyse, D. G., Cheng, D., Johnstone, D. E., Wells, G. A., Joseph, P., Patel, A., Leong, D. P., Gregus, K., Lawrence, K., Doharris, L., Conen, D., Cheung, J., Douketis, J., Wright, D., Wikkerink, S., Dechert, W., Panju, M., Azzam, K., Rapanos, T., Van Helder, T., Shroff, A., Hare, J., Kidane, B., Nguyen, T., Leydier, L., Bayaraa, V., Parlow, J., DuMerton, D. A., Thakrar, A., Shelley, J., Deligne, B., Carling, R. D., Mrkobrada, M., Dresser, G. K., Jacka, M. J., Garg, A., Hornstein, D., Winkelaar, G. B., Haider, Z. H., Lanjewar, P. P., Varughese, V., Calton, R., Ahuja, H., George, P., Sharma, A., Bhatt, K. S., Mangukiya, D. O., Nandaniya, K. V., Parekh, V. V., Pillai, A. B., Menon, V. P., Desai, S. C., Sidhu, R. S., Gupta, S. K., George, R. K., Gurunath, T. R., Drummond, L. W., Torborg, A. M., Küsel, B. S., Naidoo, P., Naidoo, D. P., Rajah, C., Farina, Z., von Rahden, R. P., Gumede, S., Chishala, C., Coetzee, E., Dyer, R. A., Diedericks, J., Bielański, P., Kaczmarek, B., Studzińska, D., Zaniewski, M., Libura, M. J., Zacharias-Nalichowski, T. M., Sega, A. A. S., Salwa, J., Kózka, M., Górka, J., Wludarczyk, A., Nowak-Kózka, I., Grudzień, P. S., Gucwa, J. W., Słowiaczek, M. P., Dobosz, P. P. D., Gögenur, I., Eriksen, J. R., Borup, T., Kirkegaard, T., Isbye, D., Sonne, A., Rasmussen, L. S., Pedersen, S., Troensegaard, H., Duus, C. L., Halle, B. M., Gundel, O. N., Bernholm, K. F., Martinsen, K. R., Pedersen, S., Itenov, T. S., Camio, E., Vázquez, C., Matarin, S., Cano, E., Álvarez-García, J., India, I., González-Osuna, A., Vives, M., Rosselló, E., Serrano, A. B., Turiel, M., Drago, L., Colombo, C., Marra, F., Mos, L., Arteni, F., Lembo, R., Ortalda, A., Passarani, S., Mokini, Z., Figueiredo, E. L., Werner, G. F., Petriz, J. L., Maia, L. N., Bergo, R. R., Precoma, D. B., Saraiva, J. F. K., Vilamajo, O. G., Allegrini, E., Benzadón, M., Parody, M. L., Duronto, E. A., Ingaramo, A. C., Parra, G. A., Novoa, D., Miller, S. A., Thomas, S., Karlapudi, S. P., Bourji, M. H., Banerjee, S., Gupta, A., Opole, I. O., Fischer, M., Jansky, P., Mendoza, V. L., Reyes, E. B., Pierson, R. J., Shields, M. O., Chow, C. K., Coriat, P., Piriou, V., Wittmann, M., Zacharowski, K., Yonga, G., Rotta-Rotta, A., Paper, M., Devereaux, P. J., Duceppe, E., Guyatt, G., Tandon, V., Rodseth, R., Biccard, B. M., Xavier, D., Szczeklik, W., Meyhoff, C. S., Vincent, J., Franzosi, M. G., Srinathan, S. K., Erb, J., Magloire, P., Neary, J., Rao, M., Rahate, P., Chaudhry, N., Mayosi, B., de Nadal, M., Paniagua Iglesias, P., Berwanger, O., Villar, J. C., Botto, F., Eikelboom, J., Sessler, D. I., Kearon, C., Pettit, S., Sharma, M., Connolly, S., Bangdiwala, S. I., Rao-Melacini, P., Hoeft, A., & Yusuf, S.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 391
- Issue
- 10137
- Pages
- 2325-2334
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2806134060
- Cited by
- 335
- References
- 25
- FWCI
- 29.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(18)30832-8
- The paper
- Devereaux, P. J., Duceppe, E., Guyatt, G., Tandon, V., Rodseth, R., Biccard, B. M., Xavier, D., Szczeklik, W., Meyhoff, C. S., Vincent, J., Franzosi, M. G., Srinathan, S. K., Erb, J., Magloire, P., Neary, J., Rao, M., Rahate, P. V., Chaudhry, N. K., Mayosi, B., . . . Yusuf, S. (2018). Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(18)30832-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.